MMP14 and neoplasm: Our study has suggested that MMP14 might not only be a potential biomarker for poor prognosis in NSCLC, but also play an important part in the microenvironment of MMP14 by regulating tumor invasion of immune cells, indicating that MMP14 can be used as a therapeutic target to modulate antitumor immune responses.